LC-MS-MS method for determination of metolazone in human plasma

E-Journal of Chemistry

Volumn 5, Issue 3, 2008, Pages 634-640

  Roy, Shikha M N ^a   Mangaonkar, Kiran V ^a   Yetal, Santosh M ^a   Joshi, Santosh S ^a  

^a RAMNARAIN RUIA COLLEGE   (India)

Author keywords

Human plasma; LC MS MS; Metolazone

Indexed keywords

EID: 52649100034     PISSN: None     EISSN: 09734945     Source Type: Journal    
DOI: 10.1155/2008/425974     Document Type: Article

References (21)

1. Guangli W, Shuhua X and Changxiao L, J Chromatogr., B, 2007, 845(1), 169-173.
2. Kim Y, Kim S and Lee W, Rapid Comm. Mass Spectrom., 2004, 18(8), 917-921.
3. Don Farthing, Domenic A. Sica, Itaf Fakhry and Todd W B Gehr, J Chromatogr., B, 1994, 653(2), 171-176.
4. Don Farthing, Itaf Farthing, Todd W B Gehr and Domenic A, J Chromatogr., B, 1990, 534, 228-232.
5. Brodie R, Chasseaud L F and Walmsley L M, J Chromatogr., B, 1981, 226(2), 526-532.
6. Vose C W, Murihead D C, Evans G L, Stevens P M and Burford S R, J Chromatogr., B, 1981, 222(2), 311-315.
7. Belair E J, Res Commun Chem Pathol Pharmacol, 1971, 2, 98-177.
8. Cangiano J L, Campos J A and Trevino A, Curr. Ther. Res., 1974, 16, 778-785.
9. Fernadez P C and Puschett J B, Am. J. Physiol., 1973, 225, 954-961.
10. Materson B J, Modern Medicine,1988, 56,47-52.
11. Miller R P, Woodworth J R and Graves D A, Curr. Ther. Res., 1988,43(6), 1133-1142.
12. Moser M., Clin. Ther., 1986, 8(5),554-562.
13. Puschett J B, Modern Medicine, 1988, 56, 53-61.
14. Schoenberger J A., Health Sci. Rev., 1982, 1,1-53.
15. Shetty BV, Campanella LA and Thomas TL, J Med. Chem., 1970,13,886-895.
16. Webster J, Mechanism and clinicalimplications, Drugs, 1985,30,32-41.
17. Guidance for Industry: Bioanalytical Method Validation. U.S. Department of Health and Human Services. FDA. CDER. CVM. May 2001.
18. U. S. Food and Drug Administration. Guidance for Industry: Statistical Approaches to Establishing Bioequivalence, January 2001.
19. Radhakrishna T, Sreenivas R D and Omreddy G, J Pharm Biomed Anal, 2002, 29(4), 593.
20. Nemutlu E and Kir S J, Pharm. Biomed. Anal., 2003, 31(2), 393-400.
21. Fernandez H, Ruperez F J and Barbas C, J. Pharm Biomed Anal., 2003, 31(3), 499-506.